- Category: Fibrosis & Cirrhosis
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
New interferon-free direct-acting antiviral regimens have high cure rates for chronic hepatitis C patients who were previously considered "difficult to treat," including HIV/HCV coinfected people and patients with liver cirrhosis, decompensated liver disease, and liver transplant recipients. New treatment can now cure a majority of people even with multiple negative predictive factors.